RESUMEN
BACKGROUND: National Comprehensive Cancer Network (NCCN) guidelines for incident prostate cancer staging imaging have been widely circulated and accepted as best practice since 1996. Despite these clear guidelines, wasteful and potentially harmful inappropriate imaging of men with prostate cancer remains prevalent. AIM: To understand changing population-level patterns of imaging among men with incident prostate cancer, we created a state-transition microsimulation model based on existing literature and incident prostate cancer cases. METHODS: To create a cohort of patients, we identified incident prostate cancer cases from 2004 to 2009 that were diagnosed in men ages 65 and older from SEER. A microsimulation model allowed us to explore how this cohort's survival, quality of life, and Medicare costs would be impacted by making imaging consistent with guidelines. We conducted a probabilistic analysis as well as one-way sensitivity analysis. RESULTS: When only imaging high-risk men compared to the status quo, we found that the population rate of imaging dropped from 53 to 38% and average per-person spending on imaging dropped from $236 to $157. The discounted and undiscounted incremental cost-effectiveness ratios indicated that ideal upfront imaging reduced costs and slightly improved health outcomes compared with current practice patterns, that is, guideline-concordant imaging was less costly and slightly more effective. CONCLUSION: This study demonstrates the potential reduction in cost through the correction of inappropriate imaging practices. These findings highlight an opportunity within the healthcare system to reduce unnecessary costs and overtreatment through guideline adherence.
Asunto(s)
Diagnóstico por Imagen/economía , Adhesión a Directriz/economía , Neoplasias de la Próstata/diagnóstico por imagen , Calidad de Vida , Anciano , Análisis Costo-Beneficio , Humanos , Masculino , Medicare/economía , Estadificación de Neoplasias , Neoplasias de la Próstata/patología , Programa de VERF , Estados UnidosRESUMEN
Importance: The National Comprehensive Cancer Network recommends imaging within 6 months after treatment for head and neck cancer (HNC). Further imaging is recommended only if the patient has symptoms or abnormal findings on physical examination. However, in many instances, asymptomatic patients continue to have imaging evaluations. Objectives: To assess practice patterns in surveillance imaging in patients with HNC and evaluate the costs associated with these imaging practices. Design, Setting, and Participants: This single-institution retrospective economic evaluation study screened 435 patients to identify patients newly diagnosed with head and neck mucosal and salivary gland malignant tumors between January 1, 2010, and December 31, 2016. Data analyses were performed from October 25, 2018, to November 24, 2020. Exposure: Imaging practice patterns. Main Outcomes and Measures: Number and costs of imaging studies during the surveillance period for all patients, patients who remained disease free, and patients who developed recurrence. Results: A total of 136 patients (mean [SD] age at diagnosis, 62 [14] years; 84 [61.8%] male; 106 [77.9%] White) with HNC were included in the study. The oropharynx was the most common subsite (64 [47.1%]), most HNCs were stage IVA (62 [45.6%]), and most patients received definitive radiation-based treatment (71 [52.2%]). During the median surveillance period of 3.2 years (range, 0.3-6.8 years), a mean (SD) of 14 (10) imaging studies were performed for all patients, with a mean (SD) total cost of $36â¯800 ($24â¯500). In patients who remained disease free, a mean (SD) of 13 (10) imaging studies were performed during the surveillance period, with a mean (SD) total cost of $35â¯000 ($21â¯700). Patients who lacked symptoms had a mean (SD) of 4 (3) studies performed per year, resulting in a mean cost of $9600 ($5900) per year. Patients who developed recurrence had more studies per year of follow-up (mean difference, 5.0; 95% CI, 3.4-6.6) and higher associated mean costs (mean difference, $10â¯600; 95% CI, $6100-$15â¯000) than patients who remained disease free. Conclusions and Relevance: In this economic evaluation study, many patients treated for HNCs received imaging studies beyond what is recommended by National Comprehensive Cancer Network guidelines. These findings suggest that the cost burden of imaging in the asymptomatic patient needs to be considered against the value obtained from routine imaging in this current health care environment.
Asunto(s)
Diagnóstico por Imagen/economía , Neoplasias de Cabeza y Cuello/diagnóstico por imagen , Neoplasias de Cabeza y Cuello/terapia , Recurrencia Local de Neoplasia/diagnóstico por imagen , Pautas de la Práctica en Medicina/economía , Costos y Análisis de Costo , Femenino , Humanos , Illinois/epidemiología , Masculino , Persona de Mediana Edad , Estudios RetrospectivosRESUMEN
INTRODUCTION: This study aimed to evaluate the costs of CRS and HIPEC and treatment of the related postoperative complications in the public healthcare system. We also aimed to identify the risk factors that increase the cost of CRS and HIPEC. MATERIALS AND METHODS: We retrospectively evaluated 80 patients who underwent CRS and HIPEC between February 2016 and November 2018 in the Department of Surgery, University Hospital of Olomouc, Czech Republic. Intraoperative factors and postoperative complications were assessed. The treatment cost included the surgery, hospital stay, intensive care unit (ICU) admission, pharmaceutical charges including medication, hospital supplies, pathology, imaging, and allied healthcare services. RESULTS: The postoperative morbidity rate was 50%, and the mortality rate was 2.5%. The mean length of hospitalisation and ICU admission was 15.44 ± 8.43 and 6.15 ± 4.12 for all 80 patients and 10.73 ± 2.93 and 3.73 ± 1.32, respectively, for 40 patients without complications, and 20.15 ± 13.93 and 8.58 ± 6.92, respectively, for 40 patients with complications. The total treatment cost reached 606,358, but the total reimbursement was 262,931; thus, the CRS and HIPEC profit margin was -343,427. Multivariate analysis showed that blood loss ≥1.000 ml (p = 0.03) and grade I-V Clavien-Dindo complications (p < 0.001) were independently associated with increased costs. CONCLUSION: The Czech public health insurance system does not fully compensate for the costs of CRS and HIPEC. Hospital losses remain the main limiting factor for further improving these procedures. Furthermore, treatment costs increase with increasing severity of postoperative complications.
Asunto(s)
Procedimientos Quirúrgicos de Citorreducción/economía , Financiación Gubernamental , Hipertermia Inducida/economía , Reembolso de Seguro de Salud/estadística & datos numéricos , Seguro de Salud , Neoplasias Peritoneales/terapia , Complicaciones Posoperatorias/economía , Adulto , Anciano , Neoplasias del Apéndice/patología , Pérdida de Sangre Quirúrgica/estadística & datos numéricos , Neoplasias Colorrectales/patología , Costos y Análisis de Costo , República Checa/epidemiología , Diagnóstico por Imagen/economía , Equipos y Suministros de Hospitales/economía , Femenino , Financiación de la Atención de la Salud , Mortalidad Hospitalaria , Humanos , Unidades de Cuidados Intensivos/economía , Unidades de Cuidados Intensivos/estadística & datos numéricos , Tiempo de Internación/economía , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Neoplasias Ováricas/patología , Neoplasias Peritoneales/secundario , Servicios Farmacéuticos/economía , Complicaciones Posoperatorias/epidemiologíaRESUMEN
Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.
Asunto(s)
Dolor Crónico/prevención & control , Dolor de la Región Lumbar/prevención & control , Manejo del Dolor/métodos , Guías de Práctica Clínica como Asunto/normas , United States Public Health Service/normas , Analgésicos Opioides/administración & dosificación , Analgésicos Opioides/uso terapéutico , Dolor Crónico/terapia , Análisis Costo-Beneficio/normas , Diagnóstico por Imagen/economía , Diagnóstico por Imagen/estadística & datos numéricos , Femenino , Humanos , Dolor de la Región Lumbar/economía , Dolor de la Región Lumbar/cirugía , Dolor de la Región Lumbar/terapia , Masculino , Manejo del Dolor/economía , Estados Unidos/epidemiologíaRESUMEN
OBJECTIVE: To determine if 3 of the Canadian Urological Association's Choosing Wisely recommendations (released in 2013-2014) related to urologic care altered physician and patient behavior. METHODS: Administrative data from Ontario, Canada between 2008 and 2017 was used. We identified 3 cohorts: First, we determined how many men >66 years of age had a serum testosterone level before starting testosterone therapy. Second, we determined how many boys undergoing an orchiopexy underwent abdominal imaging before their surgery. Third, we determined how many men with low risk prostate cancer underwent a Bone Scan after diagnosis. Piece-wise linear regression was used to evaluate for a significant change after Choosing Wisely. RESULTS: We identified 13,113 men who had their initial prescription for testosterone filled. Serum testosterone measurement increased over time, from approximately 43% to 68%. There were 9319 boys who underwent an orchiopexy. The use of pre-orchiopexy ultrasound was generally stable (approximately 55%). We identified 27,174 men with low risk prostate cancer. The use of bone scans after diagnosis decreased over time from approximately 24% to 20%. In all 3 of these groups, there was no significant change after Choosing Wisely (P = .74, P = .70, P = .72 respectively). CONCLUSION: In Ontario, there was no evidence of a significant change in 3 practice patterns that were featured in Choosing Wisely Urology recommendations. Further thought may be needed on how to translate these and future recommendations into behavior change.
Asunto(s)
Adhesión a Directriz/estadística & datos numéricos , Promoción de la Salud , Guías de Práctica Clínica como Asunto , Pautas de la Práctica en Medicina/estadística & datos numéricos , Urología , Adenocarcinoma/diagnóstico por imagen , Adenocarcinoma/secundario , Neoplasias Óseas/diagnóstico por imagen , Neoplasias Óseas/secundario , Ahorro de Costo , Criptorquidismo/diagnóstico por imagen , Criptorquidismo/cirugía , Diagnóstico por Imagen/economía , Diagnóstico por Imagen/estadística & datos numéricos , Adhesión a Directriz/economía , Humanos , Masculino , Programas Nacionales de Salud/economía , Ontario , Orquidopexia , Tomografía de Emisión de Positrones/economía , Tomografía de Emisión de Positrones/estadística & datos numéricos , Pautas de la Práctica en Medicina/economía , Utilización de Procedimientos y Técnicas , Neoplasias de la Próstata/patología , Testosterona/sangre , Testosterona/uso terapéutico , Procedimientos Innecesarios/economía , Urología/economía , Urología/estadística & datos numéricosRESUMEN
PURPOSE: The aim of this study was to assess the effect of spending patterns during the final year of life on high-cost imaging utilization in the final 3 months of life. METHODS: An academic comprehensive cancer center's radiology, cancer registry, and claims records were matched to identify decedents with dates of death from April 2013 through June 2014. Spending patterns in the final year of life were identified using group-based trajectory modeling. Descriptive analysis of CT, MRI, and PET utilization across trajectories was conducted. Multivariate logistic regressions modeled the likelihood of imaging utilization in the final 3 months of life, and a sensitivity analysis assessed the impact of spending trajectories on model fit. RESULTS: Six spending trajectories were identified. Membership in the late rising trajectory was the strongest predictor of high-cost imaging in the final 3 months of life (odds ratio, 11.61; P = .000), followed by diagnosis 12 to 6 months premortem (odds ratio, 7.49; P = .000). The likelihood of imaging the final 3 months of life was no different between high persistent and low persistent trajectory patients, despite the heterogeneity between the two patient groups. Sensitivity analysis indicated that spending trajectory improved the prediction of imaging in the final 3 months of life to a greater extent than temporal proximity to death at the time of diagnosis, which may serve as a proxy for severity and/or complexity. CONCLUSIONS: Clinical measures of severity and patients' utilization histories should be considered by hospital administrators in estimations of aggregate and individual oncologic imaging utilization. This analytic approach may aid in evaluating participation in advanced payment models.
Asunto(s)
Diagnóstico por Imagen/economía , Diagnóstico por Imagen/estadística & datos numéricos , Gastos en Salud , Neoplasias/diagnóstico por imagen , Adolescente , Adulto , Anciano , California , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sistema de Registros , Estudios Retrospectivos , Cuidado Terminal/economíaRESUMEN
The current fee-for-service system for health care reimbursement in the United Stated is argued to encourage fragmented care delivery and a lack of accountability that predisposes to insufficient focus on quality as well as unnecessary or duplicative resource utilization. Episode payment models (EPMs) seek to improve coordination by linking payments for all services related to a patient's condition or procedure, thereby improving quality and efficiency of care. The CMS Innovation Center has implemented a broadening array of EPMs. Early models with relevance to radiologists include Bundled Payment for Care Improvement (involving 48 possible clinical conditions), Comprehensive Care for Joint Replacement (involving knee and hip replacement), and the Oncology Care Model (involving chemotherapy). In July 2016, CMS expanded the range of EPMs through three new models with mandatory hospital participation addressing inpatient and 90-day postdischarge care for acute myocardial infarction, coronary artery bypass graft, and surgical hip and femur fracture treatment. Moreover, some of the EPMs include tracks that allow participating entities to qualify as an Advanced Alternative Payment Model under the Medicare Access and CHIP Reauthorization Act (MACRA), reaping the associated reporting and payment benefits. Even though none of the available EPMs are radiology specific, the models will nevertheless likely influence reimbursements for some radiologists. Thus, radiologists should partner with hospitals and other specialties in care coordination through these episode-based initiatives, thereby having opportunities to apply their imaging expertise to help lower spending while improving quality and overall levels of health.
Asunto(s)
Diagnóstico por Imagen/economía , Radiología/economía , Mecanismo de Reembolso , Planes de Aranceles por Servicios , Costos de la Atención en Salud , Humanos , Medicare , Estados UnidosRESUMEN
PURPOSE: Preventable yet clinically significant rates of medical error remain systemic, while health care spending is at a historic high. Industry-based quality improvement (QI) methodologies show potential for utility in health care and radiology because they use an empirical approach to reduce variability and improve workflow. The aim of this review was to systematically assess the literature with regard to the use and efficacy of Lean and Six Sigma (the most popular of the industrial QI methodologies) within radiology. METHODS: MEDLINE, the Allied & Complementary Medicine Database, Embase Classic + Embase, Health and Psychosocial Instruments, and the Ovid HealthStar database, alongside the Cochrane Library databases, were searched on June 2015. Empirical studies in peer-reviewed journals were included if they assessed the use of Lean, Six Sigma, or Lean Six Sigma with regard to their ability to improve a variety of quality metrics in a radiology-centered clinical setting. RESULTS: Of the 278 articles returned, 23 studies were suitable for inclusion. Of these, 10 assessed Six Sigma, 7 assessed Lean, and 6 assessed Lean Six Sigma. The diverse range of measured outcomes can be organized into 7 common aims: cost savings, reducing appointment wait time, reducing in-department wait time, increasing patient volume, reducing cycle time, reducing defects, and increasing staff and patient safety and satisfaction. All of the included studies demonstrated improvements across a variety of outcomes. However, there were high rates of systematic bias and imprecision as per the Grading of Recommendations Assessment, Development and Evaluation guidelines. CONCLUSIONS: Lean and Six Sigma QI methodologies have the potential to reduce error and costs and improve quality within radiology. However, there is a pressing need to conduct high-quality studies in order to realize the true potential of these QI methodologies in health care and radiology. Recommendations on how to improve the quality of the literature are proposed.
Asunto(s)
Ahorro de Costo/estadística & datos numéricos , Diagnóstico por Imagen/economía , Errores Médicos/economía , Mejoramiento de la Calidad/economía , Radiología/economía , Radiología/normas , Gestión de la Calidad Total/normas , Ahorro de Costo/normas , Atención a la Salud/economía , Atención a la Salud/estadística & datos numéricos , Diagnóstico por Imagen/normas , Diagnóstico por Imagen/estadística & datos numéricos , Eficiencia Organizacional , Internacionalidad , Errores Médicos/prevención & control , Errores Médicos/estadística & datos numéricos , Objetivos Organizacionales/economía , Seguridad del Paciente/economía , Seguridad del Paciente/estadística & datos numéricos , Guías de Práctica Clínica como Asunto , Mejoramiento de la Calidad/estadística & datos numéricos , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Gestión de la Calidad Total/estadística & datos numéricos , Estados Unidos , Listas de Espera , Flujo de TrabajoRESUMEN
In the past two decades, the cost associated with managing low back pain has increased significantly. Improved consciousness of how clinicians utilize resources when managing low back pain is necessary in the current economic climate. The goal of this review is to examine the component costs associated with managing low back pain and provide practical solutions for reducing healthcare costs. This is accomplished by utilizing examples from a major metropolitan area with several major academic institutions and private health care centers. It is clear that there is considerable local and national variation in the component costs of managing low back pain, including physician visits, imaging studies, medications, and therapy services. By being well informed about these variations in one's environment, clinicians and patients alike can make strides towards reducing the financial impact of low back pain. Investigation of the cost discrepancies for services within one's community of practice is important. Improved public access to both cost and outcomes data is needed.
Asunto(s)
Costos de la Atención en Salud , Dolor de la Región Lumbar/economía , Dolor de la Región Lumbar/terapia , Diagnóstico por Imagen/economía , Costos de los Medicamentos , Humanos , Manipulación Quiropráctica/economía , Modalidades de Fisioterapia/economía , Estados UnidosAsunto(s)
Organizaciones Responsables por la Atención , Diagnóstico por Imagen/tendencias , Radiología/tendencias , Prestación Integrada de Atención de Salud/economía , Prestación Integrada de Atención de Salud/tendencias , Diagnóstico por Imagen/economía , Planes de Aranceles por Servicios , Reforma de la Atención de Salud , Humanos , Radiología/economía , Radiología Intervencionista/economía , Radiología Intervencionista/tendencias , Derivación y Consulta , Estados UnidosRESUMEN
In recent years, a progressive increase in the number of medical diagnostic and interventional procedures has been observed, namely in cardiology. A significant proportion of them appear inappropriate, i.e. potentially redundant, harmful, costly, and useless. Recently, the document Medical Professionalism in the New Millennium: A Physician Charter, the American Board of Internal Medicine (ABIM) Foundation Putting the Charter into Practice program, JAMA's Less Is More and BMJ's Too Much Medicine series, and the American College of Physicians' High-Value, Cost-Conscious Care initiatives, have all begun to provide direction for physicians to address pervasive overuse in health care. In 2010, the Brody's proposal to scientific societies to indicate the five medical procedures at high inappropriateness risk inspired the widely publicized ABIM Foundation's Choosing Wisely campaign. As part of Choosing Wisely, each participating specialty society has created lists of Things Physicians and Patients Should Question that provide specific, evidence-based recommendations physicians and patients should discuss to help make wise decisions about the most appropriate individual care. In Italy, Slow Medicine launched the analogue campaign Fare di più non significa fare meglio. The Italian Association of Hospital Cardiologists (ANMCO) endorsed the initiative by recognizing the need to optimize available resources, reduce costs and avoid unnecessary cardiovascular assessments, thereby enhancing the more efficient care delivery models. An ad hoc ANMCO Working Group prepared a list of five cardiac procedures that seem inappropriate for routine use in our country and, after an internal revision procedure, these are presented here.
Asunto(s)
Cardiología , Enfermedades Cardiovasculares/diagnóstico , Enfermedades Cardiovasculares/terapia , Manejo de la Enfermedad , Mal Uso de los Servicios de Salud/prevención & control , Prescripción Inadecuada/prevención & control , Sociedades Médicas , Procedimientos Innecesarios , Cardiología/economía , Cardiología/normas , Fármacos Cardiovasculares/economía , Fármacos Cardiovasculares/uso terapéutico , Ahorro de Costo , Toma de Decisiones , Diagnóstico por Imagen/economía , Diagnóstico por Imagen/estadística & datos numéricos , Técnicas de Diagnóstico Cardiovascular/economía , Técnicas de Diagnóstico Cardiovascular/estadística & datos numéricos , Ecocardiografía/estadística & datos numéricos , Electrocardiografía Ambulatoria/estadística & datos numéricos , Medicina Basada en la Evidencia , Prueba de Esfuerzo/estadística & datos numéricos , Medicina Familiar y Comunitaria/normas , Humanos , Medicina Interna/normas , Italia , Programas Nacionales de Salud/normas , Pediatría/normas , Sociedades Médicas/normas , Procedimientos Innecesarios/economíaRESUMEN
OBJECTIVE: Ovarian cancer accounts for 50% of deaths from gynecologic malignancies. We sought to determine the cost of common methods of surveillance of women with ovarian cancer in first clinical remission. The current standard for post treatment surveillance is the National Comprehensive Cancer Network (NCCN) guidelines. METHODS: We retrospectively determined how recurrence was initially detected at our institution and a cost model was created and applied to the United States population to calculate surveillance costs using the Surveillance Epidemiology & End Results (SEER) database. RESULTS: 57% (n=60) of first recurrences were identified by increasing CA 125 level. Routine office visit identified 27% (n=29) of recurrences, and 15% (n=16) were diagnosed initially with CT scan. In 5% (5/105), CT abnormality was the only finding. 95% (100/105) of patients had either elevated CA 125 or office visit findings at time of recurrence. Of the 22,000 women diagnosed with ovarian cancer yearly, 60% (n=13,266) will have advanced disease and are likely to recur. The surveillance cost for this population for 2 years using our model is $32,500,000 using NCCN guidelines and $58,000,000 if one CT scan is obtained. CONCLUSIONS: Our data suggests that following NCCN guidelines will detect 95% of recurrences. An additional $26 million will be needed to identify the 5% of women with recurrence seen on CT only. Post treatment surveillance of ovarian cancer patients contributes significantly to health care costs. Use of CT scan to follow these patients largely increases cost with only a small increase in recurrence detection.
Asunto(s)
Antígeno Ca-125/análisis , Proteínas de la Membrana/análisis , Recurrencia Local de Neoplasia/diagnóstico , Recurrencia Local de Neoplasia/economía , Neoplasias Ováricas/diagnóstico , Neoplasias Ováricas/economía , Adulto , Anciano , Anciano de 80 o más Años , Análisis Costo-Beneficio , Diagnóstico por Imagen/economía , Diagnóstico por Imagen/métodos , Supervivencia sin Enfermedad , Femenino , Costos de la Atención en Salud , Humanos , Persona de Mediana Edad , Modelos Económicos , Examen Físico/economía , Examen Físico/métodos , Vigilancia de la Población , Guías de Práctica Clínica como Asunto , Estudios Retrospectivos , Programa de VERF , Estados UnidosRESUMEN
OBJECTIVE: The study objective was to assess the impact of a provider-led, technology-enabled radiology medical management program on high-cost imaging use. METHODS: This study was performed in the ambulatory setting of an integrated healthcare system. After negotiating a risk contract with a major commercial payer, we created a physician-led radiology medical management program to help address potentially inappropriate high-cost imaging use. The radiology medical management program was enabled by a computerized physician order entry system with integrated clinical decision support and accountability tools, including (1) mandatory peer-to-peer consultation with radiologists before order completion when test utility was uncertain on the basis of order requisition; (2) quarterly practice pattern variation reports to providers; and (3) academic detailing for targeted outliers. The primary outcome measure was intensity of high-cost imaging, defined as the number of outpatient computed tomography (CT), magnetic resonance imaging (MRI), and nuclear cardiology studies per 1000 patient-months in the payer's panel. Chi-square test was used to assess trends. RESULTS: In 1.8 million patient-months from January 2004 to December 2009, 50,336 eligible studies were performed (54.1% CT, 40.3% MRI, 5.6% nuclear cardiology). There was a 12.0% sustained reduction in high-cost imaging intensity over the 5-year period (P < .001). The number of CT studies performed decreased from 17.5 per 1000 patient-months to 14.5 (P < .01); nuclear cardiology examinations decreased from 2.4 to 1.4 (P < .01) per 1000 patient-months. The MRI rate remained unchanged at 11 studies per 1000 patient-months. CONCLUSION: A provider-led radiology medical management program enabled through health information technology and accountability tools may produce a significant reduction in high-cost imaging use.
Asunto(s)
Diagnóstico por Imagen/estadística & datos numéricos , Sistemas de Entrada de Órdenes Médicas , Pautas de la Práctica en Medicina/normas , Radiología/métodos , Procedimientos Innecesarios , Adulto , Técnicas de Imagen Cardíaca/economía , Técnicas de Imagen Cardíaca/estadística & datos numéricos , Prestación Integrada de Atención de Salud/economía , Prestación Integrada de Atención de Salud/métodos , Diagnóstico por Imagen/economía , Femenino , Humanos , Imagen por Resonancia Magnética/economía , Imagen por Resonancia Magnética/estadística & datos numéricos , Masculino , Informática Médica/métodos , Pautas de la Práctica en Medicina/economía , Radiología/educación , Cintigrafía/economía , Cintigrafía/estadística & datos numéricos , Derivación y Consulta , Tomografía Computarizada por Rayos X/economía , Tomografía Computarizada por Rayos X/estadística & datos numéricosRESUMEN
Implantations of cardiac devices therapies and ablation procedures frequently depend on accurate and reliable imaging modalities for pre-procedural assessments, intra-procedural guidance, detection of complications, and the follow-up of patients. An understanding of echocardiography, cardiovascular magnetic resonance imaging, nuclear cardiology, X-ray computed tomography, positron emission tomography, and vascular ultrasound is indispensable for cardiologists, electrophysiologists as well as radiologists, and it is currently recommended that physicians should be trained in several imaging modalities. There are, however, no current guidelines or recommendations by electrophysiologists, cardiac imaging specialists, and radiologists, on the appropriate use of cardiovascular imaging for selected patient indications, which needs to be addressed. A Policy Conference on the use of imaging in electrophysiology and device management, with representatives from different expert areas of radiology and electrophysiology and commercial developers of imaging and device technologies, was therefore jointly organized by European Heart Rhythm Association (EHRA), the Council of Cardiovascular Imaging and the European Society of Cardiac Radiology (ESCR). The objectives were to assess the state of the level of evidence and a first step towards a consensus document for currently employed imaging techniques to guide future clinical use, to elucidate the issue of reimbursement structures and health economy, and finally to define the need for appropriate educational programmes to ensure clinical competence for electrophysiologists, imaging specialists, and radiologists.
Asunto(s)
Estimulación Cardíaca Artificial/normas , Cardiología/normas , Ablación por Catéter/normas , Diagnóstico por Imagen/normas , Cardioversión Eléctrica/normas , Técnicas Electrofisiológicas Cardíacas/normas , Sociedades Médicas/normas , Estimulación Cardíaca Artificial/economía , Cardiología/economía , Cardiología/educación , Ablación por Catéter/economía , Consenso , Análisis Costo-Beneficio , Desfibriladores Implantables/normas , Diagnóstico por Imagen/economía , Diagnóstico por Imagen/métodos , Educación Médica , Cardioversión Eléctrica/economía , Cardioversión Eléctrica/instrumentación , Técnicas Electrofisiológicas Cardíacas/economía , Europa (Continente) , Medicina Basada en la Evidencia , Costos de la Atención en Salud , Humanos , Reembolso de Seguro de Salud , Marcapaso Artificial/normasRESUMEN
The balanced scorecard (BSC) represents a comprehensive management tool for organizations with the aim to focus all activities on a chosen strategy. Targets for various perspectives of the environment such as the customer, financial, process, and potential perspective are linked with concrete measures, and cause-effect relationships between the objectives are analyzed. This article shows that the BSC can also be used for the comprehensive control of a radiology department and thus provides a meaningful contribution in organizing the various diagnostic and treatment services, the management of complex clinical environment and can be of help with the tasks in research and teaching.
Asunto(s)
Servicio de Radiología en Hospital/organización & administración , Análisis Costo-Beneficio/organización & administración , Atención a la Salud/economía , Atención a la Salud/organización & administración , Grupos Diagnósticos Relacionados , Diagnóstico por Imagen/economía , Eficiencia Organizacional , Alemania , Humanos , Programas Nacionales de Salud/organización & administración , Objetivos Organizacionales/economía , Servicio de Radiología en Hospital/economíaRESUMEN
PURPOSE: This study assessed radiology requests and the influence of previous radiological procedures on their specificity and appropriateness, evaluated diagnostic outcomes and recorded the economic impact of inappropriate examinations. MATERIALS AND METHODS: We prospectively analysed 4,018 outpatient requests, the appropriateness of which was assessed using an evaluation form. Economic analysis was based on costs listed in the Italian National Health Services (NHS) national tariff as established by the Ministerial Decree of 22 July 1996. Statistical analysis was carried out using Pearson's test and univariate and multivariate logistic regression models. RESULTS: Of 4,018 outpatient requests, 57% were not included in a follow-up protocol and 56% were found to be appropriate. The diagnostic question was confirmed in 66% of cases considered appropriate (p<0.001). The existence of previous investigations had a significant impact on appropriateness and diagnostic outcome (p<0.001). The total cost of the requests was 257,317 euro, with inappropriate requests accounting for 94,012 euro (36.5%). CONCLUSIONS: We found a 56% rate of appropriate requests and demonstrated that appropriate prescriptions provided with a specific clinical question led to significantly higher confirmation rates of the diagnostic hypothesis. In addition, inappropriate requests had a major negative economic impact.
Asunto(s)
Diagnóstico por Imagen/estadística & datos numéricos , Pacientes Ambulatorios , Diagnóstico por Imagen/economía , Humanos , Italia , Modelos Logísticos , Programas Nacionales de Salud , Guías de Práctica Clínica como Asunto , Estudios Prospectivos , Derivación y Consulta/estadística & datos numéricos , Sensibilidad y Especificidad , Revisión de Utilización de RecursosRESUMEN
Health care reform will catalyze a wave of experimentation with new forms of Medicare payment as well as reorganization of the care system. These changes could profoundly affect not only the discipline of radiology but the evolution of its core technologies. To respond successfully to these challenges, radiology must aggressively build out the prognostic power of its imaging tools. It must also help create new, subspecialty clinical disciplines to use those tools and develop new payment models that capture the value created for patients and for society.
Asunto(s)
Diagnóstico por Imagen/economía , Diagnóstico por Imagen/tendencias , Predicción , Reforma de la Atención de Salud/economía , Reforma de la Atención de Salud/tendencias , Humanos , Estados UnidosRESUMEN
BACKGROUND: An increasing number of modern imaging procedures are being applied for the diagnosis of appendicitis. We compared one hundred consecutive appendectomies of the years 1988, 1998 and 2008 concerning reliability of preoperative diagnosis and resulting costs. METHODS: We analysed the first one hundred consecutive patients undergoing appendectomy during the years 1988, 1998 and 2008, 59 % were female and 41 % male. The average age was 26 years, the average BMI 21.09. The costs and results of radiological investigations (US, CT, MRI, X-ray) have been compared in all patients. The sensitivity of ultrasound and CT scan in preoperative diagnosis has been analysed. RESULTS: The number of preoperative imaging procedures for the diagnosis of appendicitis has increased over the last two decades. Simultaneously increased the costs (total costs and costs per partient) for imaging procedures. 2008 the costs were 10 times higher than 1988. CT had a higher sensitivity (77 %) in the diagnosis of appendicitis than ultrasound (33 %). The number of operations because of subacute and chronic appendicitis was lower in 2008 (34 of 100) compared with 1988 (80 of 100) and 1998 (60 of 100). In 2008 (14) we found a higher number of gangrenous and perforated appendicitis compared to 1988 (2) and 1998 (5). The majority (50 of 100) of patients in the group with acute and phlegmonous appendicitis was found in 2008. CONCLUSION: There has been an increase in the use of preoperative imaging procedures in the diagnosis of appendicitis during the last 20 years. This causes more costs in the public health system. Ultrasound as the standard imaging method for diagnosing appendicitis showed poor sensitivity. CT scans had good results concerning sensitivity, but are expensive and involve exposure to radiation for the patient.
Asunto(s)
Apendicitis/diagnóstico , Apendicitis/cirugía , Diagnóstico por Imagen/economía , Diagnóstico por Imagen/tendencias , Adulto , Apendicectomía/economía , Apendicitis/economía , Austria , Análisis Costo-Beneficio , Diagnóstico Diferencial , Servicio de Urgencia en Hospital/economía , Femenino , Humanos , Técnicas In Vitro , Laparoscopía/economía , Imagen por Resonancia Magnética/economía , Masculino , Programas Nacionales de Salud/economía , Programas Nacionales de Salud/tendencias , Sensibilidad y Especificidad , Tomografía Computarizada por Rayos X/economía , Ultrasonografía/economía , Adulto JovenRESUMEN
OBJECTIVES: The purpose of this analysis was to compare health care expenditures between insured patients with back pain, fibromyalgia syndrome, or menopause symptoms who used complementary and alternative medical (CAM) providers for some of their care to a matched group of patients who did not use any CAM care. Insurance coverage was equivalent for both conventional and CAM providers. DESIGN: Insurance claims data for 2000-2003 from Washington State, which mandates coverage of CAM providers, were analyzed. CAM-using patients were matched to CAM-nonusing patients based on age group, gender, index medical condition, overall disease burden, and prior-year expenditures. RESULTS: Both unadjusted tests and linear regression models indicated that CAM users had lower average expenditures than nonusers. (Unadjusted: $3,797 versus $4,153, p = 0.0001; beta from linear regression -$367 for CAM users.) CAM users had higher outpatient expenditures that which were offset by lower inpatient and imaging expenditures. The largest difference was seen in the patients with the heaviest disease burdens among whom CAM users averaged $1,420 less than nonusers, p < 0.0001, which more than offset slightly higher average expenditures of $158 among CAM users with lower disease burdens. CONCLUSIONS: This analysis indicates that among insured patients with back pain, fibromyalgia, and menopause symptoms, after minimizing selection bias by matching patients who use CAM providers to those who do not, those who use CAM will have lower insurance expenditures than those who do not use CAM.
Asunto(s)
Dolor de Espalda/economía , Terapias Complementarias/economía , Costo de Enfermedad , Fibromialgia/economía , Gastos en Salud , Seguro de Salud , Menopausia , Adulto , Dolor de Espalda/terapia , Estudios de Casos y Controles , Diagnóstico por Imagen/economía , Femenino , Fibromialgia/terapia , Humanos , Modelos Lineales , Masculino , Persona de Mediana Edad , WashingtónRESUMEN
BACKGROUND CONTEXT: Lumbar discectomy is one of the most common spine surgical procedures. With the exception of true emergencies (eg, cauda equina syndrome), lumbar discectomy is usually performed as an elective procedure after a prudent trial of nonoperative treatment. Although several studies have compared costs of definitive operative or nonoperative management of lumbar disc herniation, no information has been published regarding the cost of conservative care in patients who ultimately underwent surgical discectomy. PURPOSE: The purpose of this study was to determine the financial costs (and relative distribution of those costs) associated with the nonoperative management of lumbar disc herniation in patients who ultimately failed conservative care and elected to undergo surgical discectomy. STUDY DESIGN: This is a retrospective database review. PATIENT SAMPLE: The sample comprises patients within the database who underwent lumbar discectomy. OUTCOME MEASURES: The outcome measures were frequency of associated procedures and the costs of those procedures. MATERIALS AND METHODS: A search was conducted using a commercially available online database of insurance records of orthopedic patients to identify all patients within the database undergoing lumbar discectomy between 2004 and 2006. Patients were identified by American Medical Association Current Procedural Terminology code. The associated charge codes for the 90-day period before the surgery were reviewed and categorized as outpatient physician visits, imaging studies, physical therapy, injection, chiropractic manipulation, medication charges, preoperative studies, or miscellaneous charges. The frequency of each code and the percentage of patients for whom that code was submitted to the insurance companies were noted, as were the associated charges. RESULTS: In total, 30,709 patients in the database met eligibility criteria. A total of $105,799,925 was charged during the 90 days preoperatively, an average of $3,445 per patient. Average charge for discectomy procedure was $7,841. Charges for injection procedures totaled $16,211,246 or 32% of total charges, diagnostic imaging $15,648,769 (31%), outpatient visits $6,552,135 (13%), physical therapy visits $5,723,644 (11%), chiropractic manipulation $1,177,406 (2%), preoperative studies $426,976 (0.8%), medications $263,039 (0.5%), and miscellaneous charges $1,177,371 (2%). CONCLUSIONS: Charges for preoperative care of patients with lumbar disc herniation are substantial and are split almost evenly between diagnostic charges (outpatient visits, imaging, laboratory studies, and miscellaneous) and therapeutic charges (injections, physical therapy, chiropractic manipulation, and medications). Although a large number of patients will ultimately require surgical intervention, given that many patients will improve with nonoperative therapy, a trial of conservative management is appropriate. Additional studies to identify patients who may ultimately fail nonoperative treatment and would benefit from early discectomy would be beneficial.